HistoSonics Raises New Financing to Expand Histotripsy Platform Across Solid Tumors HistoSonics, the medical technology company behind the Edison® Histotripsy System, has closed a new financing round backed by Reed…
Arrowhead Pharmaceuticals Wins EU Approval for REDEMPLO® to Lower Triglycerides in Adults with Familial Chylomicronemia Syndrome Arrowhead Pharmaceuticals has secured an important regulatory milestone in Europe with the European Commission’s…
Trace Neuroscience Launches Global Clinical Development Program for TRCN-1023 in ALS Trace Neuroscience, Inc., a biopharmaceutical company focused on advancing genomic medicine for people living with neurodegenerative diseases, has announced…
Biocom Report Highlights California Life Science Industry’s $394 Billion Economic Impact and Resilience in 2025 Biocom, the largest life science membership association representing companies across California and other major life…
Syntax Bio and Ajinomoto Health & Nutrition North America Partner to Evaluate StemFit™ Media for Next-Generation Cell Therapy Workflows Syntax Bio, a synthetic biology company focused on programming the next…
Cataltheia Group Publishes Clinical Data Supporting Deseyne Contact Lens for Presbyopia in Optometry and Vision Science The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, have announced the…
AdvanCell Establishes U.S. Global Headquarters in Greater Boston, Expands Manufacturing Footprint to Support Radiopharmaceutical Growth AdvanCell, a clinical-stage radiopharmaceutical company focused on developing targeted alpha therapies for cancer, has announced…
BioTalent Canada Launches BioInsights to Deliver Labour Market Intelligence for Canada’s Bio-Economy BioTalent Canada has unveiled BioInsights, a new labour market intelligence consulting service designed to support organizations operating across…
Syntax Bio Expands Series A to $14.4 Million, Strengthens Leadership Team and Advances Cell Programming Platform for Type 1 Diabetes Therapies Syntax Bio, a synthetic biology company focused on programming…
WISE Raises €30 Million in Oversubscribed Series D Round to Advance Heron Spinal Cord Stimulation Lead and Expand Neurotechnology Platform WISE S.p.A., an Italian medical device company developing advanced implantable…
101 Therapeutics Publicly Releases Clinical and Scientific Data for Macrophage-Targeted Anti-Inflammatory Candidate as It Seeks Urgent Review for Bundibugyo Ebola Outbreak Use 101 Therapeutics Ltd. has publicly released a broad…
Incyte Japan Secures Approval for Minjuvi Combo in Relapsed or Refractory DLBCL Incyte Biosciences Japan G.K. has secured a significant regulatory milestone in Japan with the approval of Minjuvi® (tafasitamab)…